VANCOUVER, CANADA, and REHOVOT, ISRAEL, October 13, 2021 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) today announces an update to its forecast of 2021 annual sales orders for VINIA® in Israel. The Company has increased its 2021 sales orders forecast for Israel to US$ 1.6M – US$ 1.7M from the previous forecast […]
VANCOUVER, CANADA, and REHOVOT, ISRAEL, October 12, 2021 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, October 14, 2021, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host
VANCOUVER, BC, October 8, 2021 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC)announces that it has granted a total of 955,000 stock options to employees and consultants. The stock options granted are exercisable to purchase a common share of the Company at a price of CAD$ 0.34 per share for a term of
BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS Read More »
44% quarter over quarter sales growth with record VINIA® sales orders of USD 688K in Q3 Successful VINIA® pilot sales program in the U.S. market with USD 236K in sales orders in Q3 Major progress towards the commissioning of the 20Tons/year VINIA® new production facility before year end Significant accomplishments in cannabis development program; commercialisation on
Total of CAD$ 7,909,064 raised from private placement and warrants exercised VANCOUVER, CANADA, and REHOVOT, ISRAEL, October 4, 2021 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) announces the closing of its second and final tranche of the private placement announced on August 4th, 2021. Under this private placement, the Company issued a
Milestone achieved towards the imminent commissioning of the new factory, which will meet the increased demand for VINIA® On track for the conversion of the existing 2 tons/year facility to a Cannabis production facility within H1, 2022 VANCOUVER, CANADA, and REHOVOT, ISRAEL, September 9, 2021 – BioHarvest Sciences Inc.(“BioHarvest” or the “Company”) (CSE: BHSC) announces that
